384 top medical experts on Extensively Drug-Resistant Tuberculosis across 57 countries and 19 U.S. states, including 210 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Extensively Drug-Resistant Tuberculosis: Tuberculosis resistant to isoniazid and rifampin and at least three of the six main classes of second-line drugs (aminoglycosides; polypeptide agents; fluoroquinolones; thioamides; cycloserine; and para-aminosalicylic acid) as defined by the CDC.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Multidrug-Resistant Tuberculosis (4,308).
  4. Clinical Trials ClinicalTrials.gov : at least 13 including 3 Active, 7 Completed, 3 Recruiting


  

        

                    


    Computing Expert Listing ...

);